MLICM
RMD icon

Metropolitan Life Insurance Company (MetLife)’s ResMed RMD Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,932
Closed -$1.17M – 1687
2024
Q1 		$1.17M Sell
5,932
-55
-0.9% -$10.1K 0.05% 303
2023
Q4 		$1.03M Sell
5,987
-92
-2% -$14.1K 0.05% 315
2023
Q3 		$899K Sell
6,079
-324
-5% -$58.6K 0.05% 321
2023
Q2 		$1.4M Sell
6,403
-168
-3% -$37.4K 0.07% 253
2023
Q1 		$1.44M Sell
6,571
-1,715
-21% -$372K 0.07% 247
2022
Q4 		$1.72M Sell
8,286
-251
-3% -$55.1K 0.08% 249
2022
Q3 		$1.86M Sell
8,537
-95
-1% -$21.6K 0.09% 222
2022
Q2 		$1.81M Sell
8,632
-214
-2% -$45.6K 0.08% 240
2022
Q1 		$2.15M Sell
8,846
-13,633
-61% -$3.3M 0.08% 243
2021
Q4 		$5.86M Sell
22,479
-394
-2% -$102K 0.08% 197
2021
Q3 		$6.03M Sell
22,873
-763
-3% -$209K 0.09% 182
2021
Q2 		$5.83M Sell
23,636
-1,450
-6% -$305K 0.08% 190
2021
Q1 		$4.87M Sell
25,086
-1,397
-5% -$280K 0.07% 218
2020
Q4 		$5.63M Sell
26,483
-1,048
-4% -$209K 0.08% 185
2020
Q3 		$4.72M Sell
27,531
-1,092
-4% -$202K 0.08% 194
2020
Q2 		$5.5M Buy
28,623
+813
+3% +$133K 0.1% 168
2020
Q1 		$4.1M Sell
27,810
-398
-1% -$63.4K 0.08% 193
2019
Q4 		$4.37M Sell
28,208
-137
-0.5% -$19.7K 0.07% 239
2019
Q3 		$3.83M Buy
28,345
+202
+0.7% +$26.5K 0.06% 253
2019
Q2 		$3.43M Buy
28,143
+1,459
+5% +$162K 0.06% 288
2019
Q1 		$2.77M Sell
26,684
-945
-3% -$97.5K 0.05% 322
2018
Q4 		$3.15M Sell
27,629
-155
-0.6% -$16.6K 0.06% 251
2018
Q3 		$3.2M Sell
27,784
-643
-2% -$70.4K 0.05% 291
2018
Q2 		$2.94M Buy
28,427
+269
+1% +$27.2K 0.05% 329
2018
Q1 		$2.77M Buy
28,158
+254
+0.9% +$24K 0.04% 357
2017
Q4 		$2.36M Sell
27,904
-45,588
-62% -$3.77M 0.03% 447
2017
Q3 		$5.66M Sell
73,492
-66,119
-47% -$5.06M 0.04% 510
2017
Q2 		$10.9M Buy
139,611
+2,081
+2% +$149K 0.08% 246
2017
Q1 		$9.9M Buy
137,530
+286
+0.2% +$19.8K 0.07% 262
2016
Q4 		$8.52M Sell
137,244
-602
-0.4% -$36.9K 0.06% 300
2016
Q3 		$8.93M Sell
137,846
-372
-0.3% -$24.8K 0.07% 277
2016
Q2 		$8.74M Buy
138,218
+4,817
+4% +$284K 0.06% 284
2016
Q1 		$7.71M Buy
133,401
+3,922
+3% +$222K 0.06% 304
2015
Q4 		$6.95M Buy
129,479
+55
+0% +$3.1K 0.05% 337
2015
Q3 		$6.59M Sell
129,424
-1,426
-1% -$76.8K 0.05% 366
2015
Q2 		$7.38M Buy
+130,850
New +$8.26M 0.05% 362
2015
Q1 		– Sell
-124,341
Closed -$6.97M – 2397
2014
Q4 		$6.97M Buy
124,341
+705
+0.6% +$36.8K 0.05% 374
2014
Q3 		$6.09M Buy
123,636
+589
+0.5% +$30K 0.04% 413
2014
Q2 		$6.23M Sell
123,047
-961
-0.8% -$47.6K 0.04% 431
2014
Q1 		$5.54M Buy
124,008
+1,912
+2% +$85.9K 0.04% 485
2013
Q4 		$5.75M Buy
122,096
+494
+0.4% +$25K 0.04% 458
2013
Q3 		$6.42M Buy
121,602
+972
+0.8% +$47.2K 0.05% 391
2013
Q2 		$5.44M Buy
+120,630
New +$5.72M 0.04% 424

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s RMD Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of ResMed (RMD) in Q2 2024, closing a stake of 5,932 shares — an estimated $1.17M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RMD in Q2 2013 and held it in 43 quarters. The position peaked at $10.9M in Q2 2017. 772 funds tracked by Wall St. Rank hold RMD as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining ResMed position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 5,932 ResMed shares in Q2 2024, an estimated $1.17M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in ResMed in Q2 2013 and held it in 43 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s ResMed position peaked at $10.9M in Q2 2017.
  • 772 funds tracked by Wall St. Rank held ResMed as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.